抗体效价(log2) 9 K ~7 \; Z" ?$ c
| 攻毒数 6 E. E+ R0 |& K) L* _9 V9 B
| 死亡数
- T4 W* l4 ^% q | 存活数
! K6 ~: l9 _" W: |2 F | 保护率%
8 {+ l+ C7 V. v. i |
0! x9 Y' w2 ~$ a( c# M% r6 f8 Q1 o1 o
| 6
0 G% o) C! d- h9 ^, Y | 6
$ i! p" r2 J2 R" e1 v( q6 Q; b" y" h0 Z | 0( b; h0 Y' S2 F, N) w7 r
| 0! V$ D9 M/ f& j! `& w4 [
|
1
2 i X2 Q7 N+ U5 n/ [9 s | 6: Y: X( G S1 w- ]' F4 N4 o' U
| 6
* R _1 T; f/ f: W" R | 0
( ^' o/ C0 n; L( Y+ u* ]4 W | 0
2 L- N9 L8 G, @4 w |
2 5 P- h7 P+ q$ z: o0 z! T6 O7 M
| 6 ; L- B+ \$ {/ n
| 3 # P. c: s& j6 S' z
| 3 2 Y7 i1 L* ?0 c( v( Z
| 50 " L2 h3 t" i: @- v6 V7 M
|
3 + x6 a" h$ d- Z+ Y+ V4 G
| 6
! Z4 O5 R7 H X& R | 0
2 }/ f3 @% x4 z5 Y8 a9 ?/ }& i | 6
# u& P* C' m5 r; T! z+ I | 100 $ ~) @ u" g* v1 N1 v: Z( g+ a4 i/ s# i
|
4
, s1 z) S, C/ y b3 ?- p1 o0 Z9 D) x | 6 ) c4 c: W+ \+ v
| 0 ( m# S5 V' |/ o, i0 l
| 6
2 U" O( U+ e; E* Q& i7 z" v8 ~ | 100
5 a3 ^! e3 V& h J- u |
0 F" ]# s; O8 }" J* r# {/ F( f8 z日龄
3 B" R0 ~2 n" V3 C% C |
7 A3 s! P# H; _. L, n! P免疫后 + J6 a% v% K" b6 H& ~0 I8 E7 W$ A4 m
|
1周 ' y5 g1 O" E7 g4 \6 H
| 2周 5 a5 z8 L8 f7 ?
| 3周
& g' f) L5 w# T: h9 e) P | 4周 8 x6 c" a6 ~& U% Y
| 5周 8 f5 V S8 a6 h& Q) P
| 6周 7 _& ^& k* r& R u0 }# }- f# A/ o
| 7周
: J! \3 F/ D( p f3 M | 8周
8 i- z* P3 W, G& F |
304 ]3 R0 \3 x# m" R
| 1.67±0.58c# a5 c. E7 \& @) Z3 L X
| 2.75±0.96bc; w l! K* }, M2 A9 {6 u
| 1.75±0.96b
9 A8 O% e) a9 y Y | 1.00±0.00d8 a: R7 {9 a! d" g: V" `
| 0.25±0.50c
' d7 c3 g4 J- ?7 u8 k) y6 E% `, t | 0.13±0.25c
3 ?4 k" Q$ F& z; | | 0% c. T7 @4 k; ^& ~
| 0: B" M2 c- d& S# W6 c+ u% S
|
35
- E& X! O& I7 g* O5 }9 H7 I* f | 3.25±0.50ab8 j0 m) f2 @. f7 D1 k6 Y. y) k
| 3.00±0.82bc
- u$ f* u# S) S5 W; f5 `3 v5 Q$ X: W | 2.38±0.49b
4 T+ }% \5 K# L9 m | 2.00±0.00c
* s/ E0 e1 r8 |! J c- S | 1.00±0.00c3 g5 ~6 H4 I5 |, n/ C) |) W8 k
| 0.75±0.50c7 z. P7 w' h8 H' D* J
| 06 c; \+ K6 }- n9 F' l4 C' r
| 0
5 p' c5 D' t5 b- F. G |
40
- n( ~& ~7 X1 Y9 p% f2 G* C( I) J) g | 3.00±0.82ab. D% P& [8 C. B B% C7 d
| 5.75±1.71a; F: X' j' K$ b- A/ X& V
| 5.00±1.83a- V2 I0 }/ r. `# w) w5 |
| 3.25±1.50b
3 S( k a; M" k$ r* n | 3.00±0.82b% B5 U2 q) h) s# S; z
| 2.13±0.50b
- {" W1 c0 L8 r | 1.83±0.58bc# n# [ X( n9 E/ P
| 1.03±0.63bc
1 ^) v) N! @) _ |
45! z5 v" {0 F" O! H( R) `
| 3.25±1.26ab
1 x) J* X/ }0 L& M | 4.25±0.96ab P Z5 w$ \$ T( G
| 5.50±1.29a
' H- @% V* s# y& `- N | 3.75±0.96b
9 ]% i3 @+ C4 V7 i | 3.25±1.26b3 \, b/ ?7 Y# y
| 2.38±1.80b
4 r$ a) s |- k9 L% x- u2 n, K | 2.00±1.41bc; B; H L8 N e7 { ] X
| 1.13±0.63bc
8 }. r: M3 o0 s1 d( `9 d |
50
) X# m1 N+ W0 Q, T# M- B2 ~. X) E | 2.25±0.50bc! h. @! \5 V' ]% M# H4 ]: N
| 4.25±0.96ab, P$ K4 [9 X: X& r/ } b
| 4.50±2.08a
; a( D% ?" F2 ^" ]0 b | 5.75±0.50a! b# ]/ V- u: b1 `% f# Q+ }9 ]5 a
| 6.00±0.00a
4 U6 b5 c" _( z7 ^7 w | 5.00±0.00a
5 V0 |6 \9 {* P, j/ N | 3.5±0.58ab: Q# }+ G" y1 I9 ~6 }
| 1.50±0.58b9 R9 b3 Y4 X4 k/ k# q
|
55+ v: J$ p$ l4 J( F }+ C
| 3.50±0.58a
( t+ h0 g( a2 m7 i+ r7 _ | 4.75±0.50a
6 W. ^3 | V% h | 6.00±0.82b
& _* S4 r# v9 z W | 5.75±1.50a
" C2 y- L6 x$ a% u6 m& X4 c | 5.25±0.96a* E) ~7 f$ U5 e) x$ F+ Q
| 4.25±0.50a
6 c) ?6 w) j+ K h) p. b | 3.25±0.96b' x/ _+ T+ P5 |) z0 z
| 2.75±1.26ab2 D4 m& r0 a1 m/ [8 |& A( u0 ?
|
60: ^4 b4 {1 w: Q& _
| 3.50±0.58a
% Y, l( }% |. ?4 l/ U- N: g9 y' o | 5.00±0.82a
. h. E9 a. g6 m/ r3 s: a$ g1 [6 @ | 6.25±0.50a1 m9 V, T+ z+ c1 E5 J
| 5.75±0.96a
9 c& \3 X% y4 C4 T | 5.00±0.82a
7 Q" W W6 G0 o- E1 T; H | 4.13±0.85a. A2 W2 X, Z5 ~, K* D; y
| 3.25±0.96b8 [2 h5 L* }5 J5 \! O* _
| 2.25±0.96b: E& Z0 c8 Z+ k- C+ K" ?& w2 A
|